| Market Research A to Z | Company Profiles A to Z | Register | Contact Us |
| +44 (0) 203 086 8600 Call us on |
Market |
Healthcare and Medical |
Report Type |
Market Research |
Country |
Global |
Published |
23 December 2009 |
Number of Pages |
101 |
- |
|
Publisher |
Datamonitor |
File Format |
- |
Introduction
Increasing generics volume uptake will provide much needed cost-savings in the less mature markets of France, Italy, Spain, and Japan, and requires regulators to incorporate effective utilization incentives for key stakeholders. While volume will grow in the US, Germany, and the UK, regulators are increasingly looking to capture value from generics by pushing down price and speeding market access.
Scope
*An overview of generics market size, and volume and value uptake in each of the seven major markets.
*An analysis of erosion trends in terms of volume and value uptake, price changes, and number of generics entrants across the seven major markets.
*An insight into major issues shaping the US, European, and Japanese generics markets.
*An overview of the effects of recent industry consolidation, and financial performance for the leading generics companies.
Highlights
The mature generics markets of the US, Germany, and the UK, are the largest of the seven major markets (the US, France, Germany, Italy, Spain, the UK and Japan), and also show the highest levels of generic volume uptake. Indeed, erosion is greatest and most rapid in the largest generics market, the US.
The industry continues to face considerable barriers to uptake in the less mature markets of France, Italy, Spain, and Japan, with the absence of effective incentives the key issue. Conversely, pricing and regulatory pressures in the more mature generics markets act to drive down the value of these markets.
Competitive pressures across the seven major markets have intensified to the extent that the operating margin of the leading generics companies has declined between 2002 and 2008, while that of companies with a historical emerging market focus has changed little.
Reasons to Purchase
*Learn how the seven major markets compare, in terms of generics market size, and volume and value uptake.
*Gain an insight into the key trends and events which have and continue to impact on the generics market in the US, Europe, and Japan.
*Understand how consolidation and competitive market pressures have affected the operating margin of major industry players.
|
All posts are pre-moderated and must obey the house rules. |
|
Healthcare and Medical Company Profiles contain up to date financial, strategic, operational, SWOT analysis and product information on the activities of thousands of healthcare and medical companies.
Do you manage an industry specific website or blog? Are you looking to monetise your web traffic further? Are you a B2B website?
Why not offer your visitors industry specific strategic market reports and company profiles? Our Affiliate Program enables you to provide quality content on your website and to earn money from passing on visitors to our website. If a sale is made from your visitor, you earn commission (a fixed percentage of the price of a product).
Cannot find what you need? We can tailor a report for you. Complete the Custom Research Form and we will provide a quote.